223 related articles for article (PubMed ID: 33141298)
1. Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.
Fritz AS; Keller T; Kribs A; Hünseler C
Eur J Pediatr; 2021 Apr; 180(4):1193-1201. PubMed ID: 33141298
[TBL] [Abstract][Full Text] [Related]
2. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
Fritz AS; Keller T; Kribs A; Hünseler C
Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
[TBL] [Abstract][Full Text] [Related]
3. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
[TBL] [Abstract][Full Text] [Related]
4. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
Letshwiti JB; Sirc J; O'Kelly R; Miletin J
Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
[TBL] [Abstract][Full Text] [Related]
5. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
[TBL] [Abstract][Full Text] [Related]
6. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
[TBL] [Abstract][Full Text] [Related]
9. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
[TBL] [Abstract][Full Text] [Related]
10. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
11. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
Nuntnarumit P; Khositseth A; Thanomsingh P
J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
[TBL] [Abstract][Full Text] [Related]
12. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
Nuntnarumit P; Chongkongkiat P; Khositseth A
Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
[TBL] [Abstract][Full Text] [Related]
13. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
[TBL] [Abstract][Full Text] [Related]
14. Urinary NT-proBNP and ductal closure in preterm infants.
Czernik C; Metze B; Müller C; Bührer C
J Perinatol; 2013 Mar; 33(3):212-7. PubMed ID: 22743407
[TBL] [Abstract][Full Text] [Related]
15. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.
Khan SS; Sithisarn T; Bada HS; Vranicar M; Westgate PM; Hanna M
J Perinatol; 2017 Dec; 37(12):1319-1324. PubMed ID: 28906496
[TBL] [Abstract][Full Text] [Related]
16. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment.
Martinovici D; Vanden Eijnden S; Unger P; Najem B; Gulbis B; Maréchal Y
Pediatr Cardiol; 2011 Oct; 32(7):953-7. PubMed ID: 21656237
[TBL] [Abstract][Full Text] [Related]
17. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
Rodriguez-Blanco S; Oulego-Erroz I; Gautreaux-Minaya S; Perez-Muñuzuri A; Couce-Pico ML
J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Blood N-Terminal Pro-Brain Natriuretic Peptide Concentrations for Early Patent Ductus Closure in Very Preterm Infants.
Potsiurko S; Dobryanskyy D; Sekretar L
J Saudi Heart Assoc; 2020; 32(4):462-470. PubMed ID: 33537192
[TBL] [Abstract][Full Text] [Related]
19. NT-proBNP as an Early Marker of Diastolic Ventricular Dysfunction in Very-Low-Birth-Weight Infants.
Zafra-Rodríguez P; Méndez-Abad P; Lubián-López SP; Benavente-Fernández I
Pediatr Cardiol; 2019 Aug; 40(6):1165-1170. PubMed ID: 31175403
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
